Recommendations for follow-up of colorectal cancer survivors

• R. Vera ^[1] ; J. Aparicio ^[5] ; F. Carballo ^[6] ; M. Esteva ^[7] ; E. González-Flores ^[2] ; J. Santianes ^[3] ; F. Santolaya ^[8] ; J. M. Fernández-Cebrián ^[4]
  1. [1] Gobierno de Navarra

     Gobierno de Navarra

     Pamplona, España

     
  2. [2] Hospital Universitario Virgen de las Nieves

     Hospital Universitario Virgen de las Nieves

     Granada, España

     
  3. [3] Hospital Universitario Central de Asturias

     Hospital Universitario Central de Asturias

     Oviedo, España

     
  4. [4] Fundación Hospital Alcorcón

     Fundación Hospital Alcorcón

     Alcorcón, España

     
  5. [5] Hospital Universitario Y Politécnico La Fe, Valencia
  6. [6] Instituto Murciano de Investigación Biosanitaria (IMIB) Virgen de La Arrixaca
  7. [7] Gerencia Atención Primaria de Mallorca, Instituto de Investigación Sanitaria de Las Islas Baleares (IdisBa
  8. [8] Centro de Salud Ciudad San Pablo, Madrid

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 10, 2019, págs. 1302-1311
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Dialnet Métricas: 2 Citas
• Resumen

  • Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.